Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117096 | SCV000151239 | likely benign | not specified | 2013-03-27 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000117096 | SCV000539193 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all):314/10563= 2.97% |
Center for Pediatric Genomic Medicine, |
RCV000515082 | SCV000610417 | likely benign | not provided | 2017-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000550727 | SCV000632384 | benign | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000117096 | SCV000702663 | benign | not specified | 2016-10-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000515082 | SCV001950583 | benign | not provided | 2019-01-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22132891, 12819471, 23374272, 16741580, 12161590, 11753102, 27884173, 29241729) |
ARUP Laboratories, |
RCV000550727 | SCV002048929 | benign | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV000550727 | SCV002605218 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | criteria provided, single submitter | research | Potent mutations in FOXP3 gene are associated with a rare X linked condition called IPEX. It presents with immune dysregulation, secretory diarrhea, polyendocrinopathy which includes diabtes type 1, thyroiditis, growth hormone deficiency and hypoadrenalism. It is associated with pancreatic beta cell destruction. However no sufficient evidence is found to ascertain the role of this particular variant rs2232367, yet. | |
Breakthrough Genomics, |
RCV000515082 | SCV005209368 | likely benign | not provided | criteria provided, single submitter | not provided |